Great Lakes Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Great Lakes Advisors's RPRX Position: Q3 2026 in Review
Great Lakes Advisors reduced its Royalty Pharma (RPRX) stake by 23% in Q3 2026, selling an estimated $215K and leaving 12,088 shares worth $705K. The position accounts for 0.01% of the portfolio, ranked #529.
Great Lakes Advisors first reported a position in RPRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $882K in Q2 2026. 703 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- Great Lakes Advisors held 12,088 shares of Royalty Pharma worth $705K as of Q3 2026.
- Great Lakes Advisors sold 3,638 Royalty Pharma shares in Q3 2026, an estimated $215K.
- Royalty Pharma made up 0.01% of Great Lakes Advisors's portfolio in Q3 2026, its #529 holding.
- Great Lakes Advisors first reported a position in Royalty Pharma in Q2 2025 and has held it in 6 quarters since.
- Great Lakes Advisors's Royalty Pharma position peaked at $882K in Q2 2026.
- 703 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on Great Lakes Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.